Who invested in Syntis Bio?
One investor is on record as having backed Syntis Bio — develops oral therapies for obesity and rare diseases, in Biotech. Each row below says whether the round came from the investor's own portfolio page or from the press.
syntis.bioSyntis Bio investors
The funds that backed Syntis Bio are in the directory.
If they wrote this cheque, they may write yours. Pitch2Fund scores your startup against every one of them, gives you the partner to write to, and drafts the email. Free.